Weight Management
Retatrutide
A triple agonist acting on GLP-1, GIP and glucagon receptors.
What it's researched for
- Studied in research settings for appetite regulation, blood sugar control and body weight.
- Glucagon activity is studied for its effect on energy expenditure and fat use.
- One of the newest peptides in metabolic research.
READ THE RESEARCH ↗
Phase 2 trial (New England Journal of Medicine): retatrutide for obesity — up to 24.2% body-weight reduction at 48 weeks.
SIZE
£109.99
99% PURITY GUARANTEEFREE DELIVERY For laboratory research use only. Not for human consumption. Not intended to diagnose, treat, cure or prevent any disease.